in-vitro population bioequivalence [Regulatives / Guidelines]

posted by kumarnaidu – Mumbai, India, 2019-02-06 06:50  – Posting: # 19878
Views: 526

Hi,

We have conducted the Beclomethasone in-vitro population bioequivalence study for spray pattern test .Ten units for three batch of test and reference products were used for beginning life stage only .

In this experiment, three reading were measured each canisters of beginning life stage only (m=1). My question is such case , n : Number of canisters or bottles per batch, for T and R products would be 10 or 30.

According to Draft Guidance on Budesonide, Recommended Sep 2012 notation are as below:
nT ,nR : Number of canisters or bottles per batch, for T and R products.
lT , lR : Number of batches of T and R products


Data Finalresult;
set AA;
GM_T=Exp(Mean_T);
GM_R=Exp(Mean_R);
meandiff=mean_T - mean_R;
m_T=1;/* no. of stages*/
m_R=1;/* no. of stages*/
n_T=10;/* no. of bottles per batch*/
n_R=10;/* no. of bottles per batch*/
l_T=3;/* no. of batches*/
l_R=3;/* no. of batches*/

your help on this would be greatly appreciated.

Kumar Naidu

Complete thread:

Activity
 Mix view
Bioequivalence and Bioavailability Forum |  Admin contact
19,613 posts in 4,160 threads, 1,341 registered users;
online 7 (0 registered, 7 guests [including 4 identified bots]).
Forum time (Europe/Vienna): 17:57 CEST

Every sentence I utter must be understood
not as an affirmation
but as a question.    Niels Bohr

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
HTML5